VIENNA, Va., Feb. 3 /PRNewswire/ -- CEL-SCI Corporation (Amex: HIV, Berlin
Stock Exchange: LSR) today announced a change in its stock symbol effective
Monday, February 7, 2000. On that date the new stock symbol for CEL-SCI's
common stock on the American Stock Exchange will be "CVM" (CEL-SCI, VIRGINIA,
MARYLAND). The new stock symbol for the Company's warrants on the American
Stock Exchange will be "CVM.WS.A".
Geert Kersten, Chief Executive Officer of CEL-SCI said, "This change is
needed to reflect the evolution of CEL-SCI, with operations in Virginia and
Maryland, to a company whose main focus is the treatment of cancer. This
evolution has occurred as a result of the compelling responses the Company is
seeing with its cancer product, Multikine(TM), in Phase II human clinical
studies."
CEL-SCI Corporation is a biopharmaceutical company whose mission is to
harness the immune system to combat disease.
"CEL-SCI press releases are available through Company News On-Call by fax,
(800) 758-5804, Ext. 445563, or at http://www.cel-sci.com on the Internet."
SOURCE CEL-SCI Corporation
 back to top
Related links:
http://www.cel-sci.com
CONTACT:
MEDIA CONTACT: Matt Haines, The Pinnacle
Group, 516-773-2477, for CEL-SCI Corporation; or for INVESTOR
RELATIONS: Daryll Strahl of CEL-SCI Corporation, 970-377-2216
|
